Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
Compunded topical anesthetics in orthodontics. MedStar authors:
Citation: - Journal of Clinical Orthodontics. 49(6):371-7, 2015 Jun.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Gill J, Graham JW, Kravitz ND, Nicozisis JL
|
|
|
6.
|
Effectiveness of doxylamine-pyridoxine for morning sickness. MedStar authors:
- Miodovnik, Menachem
- Umans, Jason G
Year: 2016
Citation: - American Journal of Obstetrics & Gynecology. 214(5):664-6, 2016 May
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Caritis SN, Clark S, Hankins GD, Koren G, Mattison DR, Miodovnik M, Umans JG
|
|
|
7.
|
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. MedStar authors:
Year: 2019
Citation: - The Lancet Diabetes & Endocrinology. 7(8):596-605, 2019 08.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Gonzalez-Galvez G, Gron R, Halladin N, Haluzik M, Jermendy G, Kok A, Orsy P, Sabbah M, Sesti G, Silver R
|
|
|
8.
|
Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial. MedStar authors:
- Miodovnik, Menachem
- Umans, Jason G
Year: 2013
Citation: - Journal of Obstetrics & Gynaecology. 33(6):557-60, 2013 Aug.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Caritis S, Clark S, Feghali MN, Hankins G, Koren G, Matok I, Mattison DR, Miodovnik M, Nordeng H, Umans J
|
|
|
9.
|
Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy. MedStar authors:
- Miodovnik, Menachem
- Umans, Jason G
Year: 2016
Citation: - BMC Pregnancy & Childbirth. 16(1):371, 2016 Nov 24
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Caritis SN, Clark S, Hankins GD, Koren G, Matok I, Mattison DR, Miodovnik M, Umans JG
|
|
|
10.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(9):1579-86, 2016 Sep
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T
|
|
|
11.
|
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. MedStar authors:
Year: 2015
Citation: - JAMA Oncology. 1(3):296-305, 2015 Jun.
Institution: - Washington Cancer Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Adams-Campbell LL, Aragaki AK, Chlebowski RT, Johnson KC, Kaunitz A, Lessin LS, Manson JE, Nassir R, O'Sullivan MJ, Prentice RL, Rohan TE, Simon MS, Stefanick ML, Wactawski-Wende J
|
|
|
12.
|
|
|
|
13.
|
Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure. MedStar authors:
Year: 2024
Citation: - American Journal of Cardiology. 210:249-255, 2024 Jan 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Kalanatari S, Oren D, Medvedofsky D, Narang A, Imamura T, Tayazime S, Kim GH, Raikhelkar J, Sayer G, Lang RM, Uriel N
|
|
|
14.
|
A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. [Review] MedStar authors:
Year: 2016
Citation: - European Journal of Surgical Oncology. 42(8):1123-31, 2016 Aug
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Batlett D, Canbay E, Coccolini F, Deraco M, Elias D, Glehen O, Gonzaletz-Moreno S, Ishibashi H, Li Y, Mahtem H, Mizumoto A, Moran B, Morris D, Piso P, Sugarbaker PH, Verwaal V, Yonemura Y
|
|
|
15.
|
Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy. MedStar authors:
- Miodovnik, Menachem
- Umans, Jason G
Citation: - Journal of Clinical Pharmacology. 53(3):334-8, 2013 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Caritis S, Clark S, Hankins G, Koren G, Matok I, Miodovnik M, Umans J
|
|
|
16.
|
|
|
|
17.
|
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. MedStar authors:
Year: 2017
Citation: - Diabetes, Obesity & Metabolism. 19(10):1408-1415, 2017 Oct.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bergenstal RM, Bonadonna RC, Kapitza C, LixiLan-L trial investigators, Niemoeller E, Puig-Domingo M, Souhami E, Stager W, Wysham C, Yu C
|
|
|
18.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(11):1972-1980, 2016 Nov
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C
|
|
|
19.
|
Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. MedStar authors:
- Miodovnik, Menachem
- Umans, Jason G
Year: 2015
Citation: - BMC Pregnancy & Childbirth. 15:59, 2015.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Caritis SN, Clark S, Hankins GD, Koren G, Matok I, Mattison DR, Miodovnik M, Umans JG
|
|
|
20.
|
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(11):2108-2116, 2019 11.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E
|
|
|
21.
|
|
|
|
22.
|
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. MedStar authors:
Year: 2021
Citation: - Hepatology. 74(6):2952-2964, 2021 12.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Darling JM, Di Bisceglie A, Dong M, Evon DM, Fishbein DA, Fried MW, Hinestrosa F, Horne PM, Khalili M, Kixmiller S, Lok AS, Michael L, Moon JS, Morelli G, Muir AJ, Nelson DR, Pearlman B, Peter J, PRIORITIZE Study Team, Rajender Reddy K, Segal JB, Sherman KE, Shiffman ML, Sloan A, Stewart PW, Sulkowski MS, Vainorius M, Wadsworth S
|
